AzTrials
AzTrials

Breast ReconstructionNCT06629012

Autologous Nerve Graft Breast Reconstruction Neurotization

An observational study of Breast Reconstruction and Breast Cancer Patients, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

The goal of this observational study is to learn about the improvement of quality of life in accordance with breast neurotization in breast cancer patients. The patient-reported outcome was assessed by questionnaire. Read more about this study

Who is it for?
Ages 20 years and older, women only
What is being tested?
Breast reconstruction with neurotization and Breast reconstruction without neurotization
Type of treatment
Surgery or procedure
How many people
250 participants
Where
1 siteTaiwan
Study dates
29 Nov 2021to 31 Dec 2026
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing nipple-sparing mastectomy and immediate breast reconstruction

Who may be able to join

  • Patient who receive breast reconstruction
  • Patient who is willing to fill in the questionnaire

Who cannot join

  • Patient who receive breast reconstruction for the reason other than breast cancer

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chang Gung Memorial Hospital

    Taoyuan, 33305

Other trials in Taiwan

About this study

Official title: Breast Neurotization During Breast Reconstruction Enhances Quality of Life

The goal of this observational study is to learn about the improvement of quality of life in accordance with breast neurotization in breast cancer patients. The patient-reported outcome was assessed by questionnaire.

Being tested
Breast reconstruction with neurotization, Breast reconstruction without neurotization
Keywords
breast reconstruction, nipple-sparing mastectomy, breast neurotization, quality of life, autologous nerve graft, nipple sensation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Breast reconstruction with neurotizationProcedure or surgery

    Patients received breast reconstruction with neurotization procedure

  • Breast reconstruction without neurotizationProcedure or surgery

    Patients received breast reconstruction without neurotization

Study groups in NCT06629012
Study groupRoleWhat they receive
Innervated groupPatients received breast neurotization
Receives: Procedure: Breast reconstruction with neurotization
Non-innervated groupPatients did not receive breast neurotization
Receives: Procedure: Breast reconstruction without neurotization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pre-operative Quality of life

    Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms

    Measured: Before breast reconstructive surgery

  2. Post-operative-two-year Quality of life

    Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms

    Measured: Two-year after breast reconstructive surgery

  3. Post-operative-one-year Quality of life

    Patient-reported outcome assessed by the BREAST-Q™ Reconstruction module questionnaire and a additional questionnaire regarding sensation, nipple satisfaction, and breast symptoms

    Measured: One-year after breast reconstructive surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Oct 2024
  2. Study start29 Nov 2021
  3. Primary completion31 Dec 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
250 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06629012
Sponsor's protocol ID
202101923B0-N
Status last verified
Oct 2026
First submitted
3 Oct 2024
Last updated
22 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Patient privacy

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in